Results 221 to 230 of about 43,707 (255)
Some of the next articles are maybe not open access.

Complex synthetic lethality in cancer

Nature Genetics, 2023
The concept of synthetic lethality has been widely applied to identify therapeutic targets in cancer, with varying degrees of success. The standard approach normally involves identifying genetic interactions between two genes, a driver and a target. In reality, however, most cancer synthetic lethal effects are likely complex and also polygenic, being ...
Colm J. Ryan   +3 more
openaire   +2 more sources

Synthetic lethality and cancer

Nature Reviews Genetics, 2017
A synthetic lethal interaction occurs between two genes when the perturbation of either gene alone is viable but the perturbation of both genes simultaneously results in the loss of viability. Key to exploiting synthetic lethality in cancer treatment are the identification and the mechanistic characterization of robust synthetic lethal genetic ...
Nigel J O'Neil   +2 more
exaly   +3 more sources

Synthetic Lethal Screen

2005
The synthetic lethal screen is a method of isolating novel mutants whose survival is dependent on a gene of interest. Combining the colony-color assay with a synthetic lethal screen offers a means to visually detect a mutant that depends on a plasmid for survival. Screening for synthetic lethals can be achieved in four steps.
Leslie, Barbour, Wei, Xiao
openaire   +2 more sources

Searching for synthetic lethality in cancer

Current Opinion in Genetics & Development, 2011
The incentive to develop personalised therapy for cancer treatment is driven by the premise that it will increase therapeutic efficacy and reduce toxicity. Understanding the underlying cellular and molecular basis of the disease has been extremely important in the design of these novel therapies; however, identifying new drug targets for personalised ...
Rachel, Brough   +4 more
openaire   +2 more sources

Synthetic dosage lethality

2002
Publisher Summary Identification of proteins that interact to perform a common function is crucial to understanding the mechanisms of cellular processes. Both genetic and biochemical methods are used to uncover an interaction between two proteins. In yeast, many genetic screens have been developed, which begin with the mutation of a gene of interest ...
Vivien, Measday, Philip, Hieter
openaire   +2 more sources

Synthetic lethality and beyond

Science Translational Medicine, 2016
DNA damage–induced binding of DNA methyltransferases maximizes the efficacy of poly(ADP-ribose) polymerase inhibitors.
openaire   +2 more sources

Synthetic Lethality in Cancer Therapeutics [PDF]

open access: yesAnnual Review of Cancer Biology, 2017
Treatment with targeted drugs has primarily focused on the genes and pathways that are mutated in cancer, which severely limits the repertoire of drug targets. Synthetic lethality exploits the notion that the presence of a mutation in a cancer gene is often associated with a new vulnerability that can be targeted therapeutically, thus greatly ...
Roderick L Beijersbergen   +2 more
exaly   +2 more sources

Synthetic Lethal Interactions in Cancer Therapy

Current Cancer Drug Targets, 2016
Silencing of two or more complementary signaling pathways can lead to cell death, while loss of any single genetic function does not show a severe phnotype, this kind of inter action is coined as "synthetic lethality". Nowadays, synthetic lethality has become a widely used anti-cancer strategy.We reviewed the synthetic lethal interactions exploited in ...
Xinwei, Geng   +3 more
openaire   +2 more sources

Collateral lethality: A unique type of synthetic lethality in cancers

Pharmacology & Therapeutics
Genetic interactions play crucial roles in cell-essential functions. Intrinsic genetic defects in tumors typically involve gain-of- and loss-of-function mutations in tumor suppressor genes (TSGs) and oncogenes, respectively, providing potential antitumor vulnerabilities.
Zichen, Zhao   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy